Advances in Surface Plasmon Resonance-Based Biosensor Technologies for Cancer Cell Detection

Table 3

Performance parameters when layer of TiSi₂ and layer of BP = at 633 nm wavelength.

Type of cell	RI of cell	Targeted RI	Minimum reflectance	S	θ1	θ2	FWHM	DA	FoM
Basal (skin cancer)	1.38	1.38	0.33046	195.4	75.26	80.6	5.38	0.19	36.32
Basal (normal cell)	1.36	1.36	0.27794	167.6	72.04	77.1	5.04	0.20	33.25
HeLa (cervical cancer)	1.392	1.39	0.38627	212.4	77.24	82.4	5.2	0.19	40.85
HeLa (normal cell)	1.368	1.365	0.28677	168.4	72.78	77.9	5.16	0.19	32.64
Jurkat (blood cancer)	1.39	1.39	0.38627	212.4	77.24	82.4	5.2	0.19	40.85
Jurkat (normal cell)	1.376	1.375	0.31213	186.6	74.38	79.7	5.35	0.19	34.88
PCI-2 (adrenal gland cancer)	1.395	1.395	0.42904	218.6	78.4	83.2	4.83	0.21	45.26
PCI-2 (normal cell)	1.381	1.38	0.33046	195.4	75.26	80.6	5.38	0.19	36.32
MDA-MB-231 (breast cancer)	1.399	1.4	0.48642	203.6	79.8	83.8	4.01	0.25	50.77
MDA-MB-231 (normal cell)	1.385	1.385	0.35444	202.6	76.2	81.6	5.36	0.19	37.80
MCF-7 (breast cancer)	1.401	1.4	0.48642	203.6	79.8	83.8	4.01	0.25	50.77
MCF-7 (normal cell)	1.387	1.385	0.35444	202.6	76.2	81.6	5.36	0.19	37.80